cisplatin + cyclophosphamide + docetaxel + epirubicin + gemcitabine

This is a combination chemotherapy regimen consisting of five anticancer drugs: cisplatin, cyclophosphamide, docetaxel, epirubicin, and gemcitabine. Each component has different mechanisms of action: - Cisplatin is a platinum-based agent that crosslinks DNA, interfering with cell division - Cyclophosphamide is an alkylating agent that damages DNA and prevents cancer cell replication - Docetaxel is a taxane that disrupts microtubule function during cell division - Epirubicin is an anthracycline that intercalates DNA and inhibits topoisomerase II - Gemcitabine is a nucleoside analog that interferes with DNA synthesis This multi-agent combination likely targets different cellular mechanisms to enhance anticancer effects while potentially reducing resistance development.